Cargando…

Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans

BACKGROUND: Few adults at high risk for atherosclerotic cardiovascular disease events use a PCSK9i (proprotein convertase subtilisin/kexin type 9 inhibitor). METHODS AND RESULTS: Using data from the US Veterans Health Administration, we identified veterans who initiated a PCSK9i between January 2018...

Descripción completa

Detalles Bibliográficos
Autores principales:	Derington, Catherine G., Colantonio, Lisandro D., Herrick, Jennifer S., Cook, James, King, Jordan B., Rosenson, Robert S., Poudel, Bharat, Monda, Keri L., Navar, Ann Marie, Mues, Katherine E., Stevens, Vanessa W., Nelson, Richard E., Vanneman, Megan E., Muntner, Paul, Bress, Adam P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174184/ https://www.ncbi.nlm.nih.gov/pubmed/33821686 http://dx.doi.org/10.1161/JAHA.120.019254

Ejemplares similares

Adherence to Statin Therapy Among US Adults Between 2007 and 2014
por: Colantonio, Lisandro D., et al.
Publicado: (2019)

Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era
por: Rosenson, Robert S., et al.
Publicado: (2019)

Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2023)

Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV‐‐Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015
por: Rosenson, Robert S., et al.
Publicado: (2018)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2021)

Trends in Statin Use Among US Adults With Chronic Kidney Disease, 1999–2014
por: Mefford, Matthew T., et al.
Publicado: (2019)

Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
por: Booth, John N., et al.
Publicado: (2018)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke
por: Bress, Adam P., et al.
Publicado: (2016)

Lipoprotein(a) and the Risk for Coronary Heart Disease and Ischemic Stroke Events Among Black and White Adults With Cardiovascular Disease
por: Colantonio, Lisandro D., et al.
Publicado: (2022)

Choosing Veterans Affairs: Determinants of post-9/11 Veterans’ enrollment in Veterans Affairs health care
por: Vanneman, Megan E., et al.
Publicado: (2023)

Health Care Access Expansions and Use of Veterans Affairs and Other Hospitals by Veterans
por: Yoon, Jean, et al.
Publicado: (2022)

Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults
por: McKinley, Emily C., et al.
Publicado: (2021)

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline
por: Alanaeme, Chibuike J., et al.
Publicado: (2022)

Outcomes of Veterans Treated in Veterans Affairs Hospitals vs Non–Veterans Affairs Hospitals
por: Yoon, Jean, et al.
Publicado: (2023)

Comparing Driving Miles for Department of Veterans Affairs–delivered Versus Department of Veterans Affairs–purchased Cataract Surgery
por: Pettey, Warren B.P., et al.
Publicado: (2021)

Association Between Triglycerides and Incident Cognitive Impairment in Black and White Adults in the Reasons for Geographic and Racial Differences in Stroke Study
por: Rosenson, Robert S., et al.
Publicado: (2023)

PCSK9: The Nexus of Lipoprotein Metabolism and Inflammation in COVID-19
por: Goonewardena, Sascha N., et al.
Publicado: (2023)

Estimating the Cost of Surgical Care Purchased in the Community by the Veterans Health Administration
por: Wagner, Todd H., et al.
Publicado: (2021)

Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed‐Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020
por: Derington, Catherine G., et al.
Publicado: (2023)

County-level Predictors of Growth in Community-based Primary Care Use Among Veterans
por: Gordon, Sarah H., et al.
Publicado: (2021)

Partnership Forum: The Role of Research in the Transformation of Veterans Affairs Community Care
por: Mengeling, Michelle A., et al.
Publicado: (2021)

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
por: Derington, Catherine G., et al.
Publicado: (2021)

Association of Quality of Care With Where Veterans Choose to Get Knee Replacement Surgery
por: Giori, Nicholas J., et al.
Publicado: (2022)

How well can familial hypercholesterolemia be identified in an electronic health record database?
por: Mues, Katherine E, et al.
Publicado: (2018)

Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction
por: Mohanty, April F., et al.
Publicado: (2021)

2039: Modifiable risk factors Versus age on developing high predicted cardiovascular disease risk in African Americans
por: Bress, Adam, et al.
Publicado: (2018)

Modifiable Risk Factors Versus Age on Developing High Predicted Cardiovascular Disease Risk in Blacks
por: Bress, Adam P., et al.
Publicado: (2017)

New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
por: King, Jordan B., et al.
Publicado: (2023)

Anticipating VA/non-VA care coordination demand for Veterans at high risk for hospitalization
por: Vanneman, Megan E., et al.
Publicado: (2022)

Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
por: Hubbard, Demetria, et al.
Publicado: (2021)

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
por: Rosenson, Robert S., et al.
Publicado: (2016)

Association Between Mental Health Conditions and Care Fragmentation: A National Study of High-Risk Older Veterans
por: Trivedi, Ranak, et al.
Publicado: (2020)

Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021)

Agreement of claims-based methods for identifying sepsis with clinical criteria in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort
por: Donnelly, John P., et al.
Publicado: (2020)

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
por: Derington, Catherine G., et al.
Publicado: (2022)

The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old
por: Colantonio, Lisandro D., et al.
Publicado: (2016)

Cardiovascular outcomes among HIV-infected veterans receiving atazanavir
por: LaFleur, Joanne, et al.
Publicado: (2017)

PCSK9 loss-of-function variants and risk of infection and sepsis in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort
por: Mitchell, Kellie A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o0b0sv277sbrdabm21ll6p0idv